Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Molecular oncology"
DOI: 10.1002/1878-0261.13116
Abstract: Circulating tumor DNA (ctDNA) has demonstrated great potential as a non-invasive biomarker to assess minimal residual disease (MRD) and to profile tumor genotypes in patients with non-small cell lung cancer (NSCLC). However, little is known… read more here.
Keywords: early stage; locally advanced; stage locally; resection ... See more keywords